Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial.

G RastrelliS CiprianiF LottiI CellaiP ComeglioS FilippiV BoddiP A Della CameraR SantiL BoniG NesiS SerniM GacciM MaggiLinda Vignozzi

Published in: Journal of endocrinological investigation (2022)

Twenty-four weeks of TTh in TD men with BPH and MetS improves ultrasound, molecular and histological proxies of prostate inflammation. This does not result in symptom improvement.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
middle aged
oxidative stress
magnetic resonance imaging
replacement therapy
computed tomography
ultrasound guided
contrast enhanced ultrasound